Vivani Medical (Nasdaq:VANI) announced today that it entered into a securities purchase agreement worth $15 million in proceeds. The company entered the agreement with an institutional investor. It covers the purchase of just shy of 4 million shares of common stock and warrants to purchase common stock. Alameda, California-based Vivani priced the shares at $3.80 […]
Weight loss
Fractyl Health goes the IPO route
Fractyl Health — developer of medtech and gene therapies to reverse diabetes and obesity — began trading on the Nasdaq today under the symbol GUTS. Lexington, Massachusetts–based Fractyl Health priced its 7,333,333 shares of common stock at $15 per share, enabling it to bring in about $110 million from the IPO. The company expected the […]
UK NHS trust treats first patients with Allurion weight loss balloon
Allurion (NYSE:ALUR) announced today that the Somerset NHS Foundation Trust introduced its gastric balloon for weight loss. This marks the first NHS trust in the UK and the first non-private sector organization in the world to introduce the balloon. Natick Massachusetts-based Allurion designed the swallowable balloon to require no surgery, endoscopy or anaesthesia. Once swallowed, […]
Levita Magnetics takes its MARS robotic surgery platform international
Levita Magnetics today announced the international launch of its MARS (magnetic-assisted robotic surgery) system with its placement at Hospital Luis Tisne in Santiago, Chile. Dr. Julio Jimenez used the system to perform same-day-discharge cholecystectomies (gallbladder removal) and bariatric surgeries. Jiminez previously helped Levita Magnetics with its clinical trials, said Levita Magnetics founder, CEO and President […]
Signos raises $20M for AI-powered CGM tech with backing from Google Ventures, Dexcom Ventures
Signos announced that it raised $20 million in a Series B round to support its AI-powered continuous glucose monitor (CGM) technology. San Francisco-based Signos develops a comprehensive metabolic health platform. It includes a proprietary AI engine with a CGM to provide real-time data and recommendations for weight management. Signos aims for its metabolic-led solution to […]
First commercial cases completed with Levita Magnetics’ MARS surgical robot
Levita Magnetics today announced the world’s first commercial use for its MARS magnetic-assisted robotic surgery platform. Dr. Matthew Kroh and Dr. Andrew Strong performed the first minimally invasive procedures with the system at the Cleveland Clinic. The procedures took place last month, just over a month after the FDA cleared the MARS system. In a […]
Moon Surgical announces first commercial Maestro surgical robot cases in France
Moon Surgical today announced the successful completion of the first 10 laparoscopic surgeries with its Maestro system in France. The procedures — bariatric and abdominal surgery procedures — took place at the Arnault Tzanck Institute in Nice, France. Laparoscopic surgeons Dr. Benjamin Cadière and Dr. Georges Debs performed them. According to a news release, the […]
Intuitive leaders weigh in on GLP-1 drugs and surgical robotics procedures
Intuitive Surgical executives say they see benefits to their business from GLP-1 weight loss drugs, even if investors aren’t quite so sure. Intuitive’s stock slid in after-hours trading today after the company posted Q3 results that exceeded analysts’ expectations on profits but fell short on sales. Even if they had beat The Street on both […]
Weight loss balloon maker Allurion goes public on NYSE through SPAC merger
Allurion Technologies announced that it completed a SPAC merger and began trading on the New York Stock Exchange. Natick, Massachusetts-based Allurion went public on Aug. 2 under the ALUR ticker. The business combination took place with Compute Health Acquisition Corp, a special purpose acquisition company (SPAC). Allurion develops an artificial intelligence-powered weight loss program. Its program […]
Medtronic, Allurion partner on AI-based weight loss tech
Allurion announced today that it entered into a pilot collaboration with Medtronic . Allurion and Medtronic inked a sales agency agreement in the Central and Eastern Europe, Middle East, and Africa (CEMA) region. The agreement aims to expand access to Allurion’s artificial intelligence-powered weight loss program. It enables Allurion to offer its Allurion Balloon and […]
Data shows improved outcomes with DarioHealth’s chronic condition management platform
DarioHealth (Nasdaq:DRIO) today announced real-world study data on the impact of managing diabetes and weight on a single digital platform. New York-based DarioHealth presented the published retrospective, real-world study observing its digital therapeutics platform at the Advanced Technologies and Treatments for Diabetes (ATTD) Conference in Barcelona. The company analyzed 12 months of data for a […]